Large European cohort data suggest hydroxyurea pregnancy exposure in sickle cell disease is not linked to congenital malformations, supporting nuanced clinical decision-making.

Columnist Michelle Harlan, who's currently taking hydroxyurea to treat her sickle beta-zero thalassemia, considers some other ...

Please provide your email address to receive an email when new articles are posted on . Use of hydroxyurea did not reduce ovarian reserve among girls and young women with sickle cell disease.

Machine learning identified RDW and HGB as key predictors of hydroxyurea resistance in polycythemia vera, aiding early identification and treatment adjustment. The PV-AIM study used electronic health ...